Barclays’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175M Sell
1,906,965
-206,289
-10% -$18M 0.03% 333
2026
Q1
$180M Sell
2,113,254
-581,983
-22% -$51.9M 0.04% 322
2025
Q4
$213M Sell
2,695,237
-280,839
-9% -$22M 0.05% 271
2025
Q3
$238M Sell
2,976,076
-698,538
-19% -$59.6M 0.05% 258
2025
Q2
$334M Sell
3,674,614
-2,381,465
-39% -$217M 0.08% 174
2025
Q1
$567M Buy
6,056,079
+1,320,358
+28% +$118M 0.16% 87
2024
Q4
$431M Sell
4,735,721
-2,908,468
-38% -$278M 0.12% 112
2024
Q3
$794M Buy
7,644,189
+2,132,747
+39% +$217M 0.21% 58
2024
Q2
$535M Buy
5,511,442
+685,316
+14% +$63.2M 0.16% 86
2024
Q1
$435M Buy
4,826,126
+1,243,405
+35% +$105M 0.15% 119
2023
Q4
$286M Sell
3,582,721
-2,376,125
-40% -$179M 0.1% 171
2023
Q3
$424M Buy
5,958,846
+3,168,911
+114% +$237M 0.26% 68
2023
Q2
$215M Sell
2,789,935
-377,815
-12% -$29.2M 0.14% 145
2023
Q1
$238M Sell
3,167,750
-977,338
-24% -$72.7M 0.11% 110
2022
Q4
$327M Buy
4,145,088
+2,079,979
+101% +$156M 0.15% 105
2022
Q3
$145M Sell
2,065,109
-7,683,602
-79% -$602M 0.16% 134
2022
Q2
$781M Buy
9,748,711
+5,062,962
+108% +$396M 0.48% 31
2022
Q1
$355M Sell
4,685,749
-1,576,132
-25% -$125M 0.28% 72
2021
Q4
$534M Buy
6,261,881
+2,235,332
+56% +$175M 0.2% 94
2021
Q3
$304M Buy
4,026,549
+364,770
+10% +$29M 0.14% 115
2021
Q2
$298M Buy
3,661,779
+231,002
+7% +$18.9M 0.14% 114
2021
Q1
$270M Buy
3,430,777
+359,305
+12% +$28.2M 0.15% 103
2020
Q4
$263M Buy
3,071,472
+2,118,906
+222% +$175M 0.14% 112
2020
Q3
$73.5M Buy
952,566
+338,282
+55% +$25.8M 0.04% 294
2020
Q2
$45M Sell
614,284
-53,405
-8% -$3.79M 0.03% 361
2020
Q1
$44.3M Sell
667,689
-1,754,947
-72% -$124M 0.04% 346
2019
Q4
$167M Buy
2,422,636
+1,353,321
+127% +$92.3M 0.09% 177
2019
Q3
$78.6M Sell
1,069,315
-1,346,924
-56% -$97.7M 0.05% 304
2019
Q2
$173M Buy
2,416,239
+659,933
+38% +$46.8M 0.11% 163
2019
Q1
$120M Sell
1,756,306
-7,677
-0.4% -$496K 0.08% 189
2018
Q4
$105M Buy
1,763,983
+815,119
+86% +$51M 0.08% 182
2018
Q3
$63.5M Buy
948,864
+218,306
+30% +$14.5M 0.04% 326
2018
Q2
$47.3M Sell
730,558
-770,596
-51% -$50.4M 0.04% 378
2018
Q1
$108M Buy
1,501,154
+481,105
+47% +$34.6M 0.08% 202
2017
Q4
$77M Buy
1,020,049
+343,025
+51% +$25M 0.06% 252
2017
Q3
$49.3M Sell
677,024
-232,933
-26% -$16.8M 0.05% 299
2017
Q2
$67.5M Buy
909,957
+137,550
+18% +$10.2M 0.07% 212
2017
Q1
$56.5M Sell
772,407
-171,316
-18% -$12M 0.06% 224
2016
Q4
$61.8M Buy
943,723
+668,870
+243% +$45.9M 0.07% 229
2016
Q3
$20.4M Sell
274,853
-11,577
-4% -$856K 0.02% 543
2016
Q2
$21M Buy
286,430
+17,952
+7% +$1.28M 0.03% 501
2016
Q1
$18.8M Sell
268,478
-406,205
-60% -$27M 0.03% 494
2015
Q4
$44.5M Buy
674,683
+298,835
+80% +$19.9M 0.05% 313
2015
Q3
$23.7M Sell
375,848
-244,715
-39% -$16M 0.03% 525
2015
Q2
$40.3M Sell
620,563
-1,599,504
-72% -$109M 0.05% 368
2015
Q1
$153M Buy
2,220,067
+1,532,441
+223% +$106M 0.18% 91
2014
Q4
$47.4M Sell
687,626
-81,472
-11% -$5.5M 0.05% 372
2014
Q3
$50M Buy
769,098
+267,560
+53% +$17.6M 0.05% 322
2014
Q2
$34.1M Sell
501,538
-242,501
-33% -$16.3M 0.04% 441
2014
Q1
$47.6M Sell
744,039
-109,961
-13% -$6.93M 0.05% 313
2013
Q4
$55.5M Buy
854,000
+114,754
+16% +$7.34M 0.06% 298
2013
Q3
$43.6M Sell
739,246
-18,909
-2% -$1.12M 0.05% 337
2013
Q2
$43.4M Buy
+758,155
New +$45M 0.05% 296

Other funds holding CL

Barclays's CL Position: Q2 2026 in Review

Barclays reduced its Colgate-Palmolive (CL) stake by 9.8% in Q2 2026, selling an estimated $18M and leaving 1,906,965 shares worth $175M. The position accounts for 0.03% of the portfolio, ranked #333.

Barclays first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $794M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Barclays held 1,906,965 shares of Colgate-Palmolive worth $175M as of Q2 2026.
  • Barclays sold 206,289 Colgate-Palmolive shares in Q2 2026, an estimated $18M.
  • Colgate-Palmolive made up 0.03% of Barclays's portfolio in Q2 2026, its #333 holding.
  • Barclays first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Colgate-Palmolive position peaked at $794M in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.